Details
Title
Plasma interleukin-1α and interleukin-8 in female dogs with non-metastatic and metastatic malignant mammary gland tumoursJournal title
Polish Journal of Veterinary SciencesYearbook
2022Volume
vol. 25Issue
No 2Authors
Affiliation
Szczubiał, M. : Department and Clinic of Animal Reproduction, Faculty of Veterinary Medicine, University of Life Sciences, Gleboka 30, 20-612 Lublin, Poland ; Łopuszyński, W. : Department of Pathomorphology and Forensic Veterinary Medicine, Faculty of Veterinary Medicine, University of Life Sciences, Gleboka 30, 20-612 Lublin, Poland ; Dąbrowski, R. : Department and Clinic of Animal Reproduction, Faculty of Veterinary Medicine, University of Life Sciences, Gleboka 30, 20-612 Lublin, Poland ; Bochniarz, M. : Department and Clinic of Animal Reproduction, Faculty of Veterinary Medicine, University of Life Sciences, Gleboka 30, 20-612 Lublin, Poland ; Brodzki, P. : Department and Clinic of Animal Reproduction, Faculty of Veterinary Medicine, University of Life Sciences, Gleboka 30, 20-612 Lublin, PolandKeywords
IL-1α ; IL-8 ; canine mammary tumours ; plasma ; metastasesDivisions of PAS
Nauki Biologiczne i RolniczeCoverage
317-324Publisher
Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in OlsztynBibliography
Abdelmegeed SM, Mohammed S (2018) Canine mammary tumors as a model for human disease. Oncol Lett 15: 8195-8205.
Andaluz A, Yeste M, Rodriguez-Gil JE, Rigau T, Garcia F, Rivera del Alamo MM ( 2016) Pro-inflammatory cytokines: Useful markers for the diagnosis of canine mammary tumours? Vet J 210: 92-94.
Baba OK, Sood NK, Gupta K (2019) Clinical evaluation of glycoproteins and inflammatory cytokines in the serum of dogs affected with canine mammary cancer. Proc Natl Acad Sci India Sect B Biol Sci 89: 1465-1469.
Baker KJ, Houston A, Brint E (2019) IL-1 family members in cancer; two sides to every story. Front Immunol 10: 1197.
Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpe S, Vermeulen PB, Dirix LY (2004) Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10: 7157-7162.
Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissiere F, Laune D, Roques S, Lazennec G (2007) Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 9: R15.
Chen Y, Shi M, Yu GZ, Qin XR, Jin G, Chen P, Zhu MH (2012) Interleukin-8, a promising predictor for prog nosis of pancreatic cancer. World J Gastroenterol 18: 1123-1129.
Chiu JW, Hanafi ZB, Chew LC, Mei Y, Liu H (2021) IL-1α processing, signaling and its role in cancer progression. Cells 10: 92.
De Andres PJ, Illera JC, Caceres S, Diez L, Perez -Alenza MD, Pena L (2013) Increased levels of inter leukins 8 and 10 as findings of canine inflammatory mammary cancer. Vet Immunol Immunopathol 152: 245-251.
Derin D, Soydinc HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E (2007) Serum IL-8 and IL-12 levels in breast cancer. Med Oncol 24: 163-168.
Elston CW, Ellis IO (1998) Assessment of histological grade. In: Systemic Pathology. Churchill Livingstone, London, pp 356-384.
Estrela-Lima A, Araujo MS, Soares RP, Ribeiro LG, Damasceno KA, Costa AT, Teixeira-Carvalho A, Martins-Filho OA, Cassali GD (2016) Plasma biomarkers profile of female dogs with mammary carcinoma and its association with clinical and pathological features. Vet Comp On-col 14: 88-100.
Fasoulakis Z, Kolios G, Papamanolis V, Kontomanolis EN (2018) Interleukins associated with breast cancer. Cureus 10: e3549.
Fernandes JV, Cobucci RN, Jatoba CA, Fernandes TA, de Azevedo JW, de Araujo JM (2015) The role of the mediators of inflammation in cancer development. Pathol Oncol Res 21: 527-534.
Gelaleti GB, Jardim BV, Leonel C, Moschetta MG, Zuccari DA (2012) Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias. Vet Immunol Immunopathol 146: 106-112.
Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, Birnbaum D, Guan JL, Dontu G, Wicha MS (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120: 485-497.
Goldschmidt M, Pena L, Rasotto R, Zappulli V (2011) Classification and grading of canine mammary tumors. Vet Pathol 48: 117-131.
Haas M, Kaup FJ, Neumann S (2015) Evaluation of serum interleukin-8 (CXCL8) concentrations in tumor bearing dogs. Am J Anim Vet Sci 10: 202-211.
Holen I, Lefley DV, Francis SE, Rennicks S, Bradbury S, Coleman RE, Ottewell P (2016) IL-1 drives breast cancer growth and bone metas-tasis in vivo. Oncotarget 7: 75571-75584.
Irac SE, Oksa A, Jackson K, Herndon A, Allavena R, Palmieri C (2019) Cytokine expression in canine lym phoma, osteosarcoma, mammary gland tumour and melanoma: comparative aspects. Vet Sci 6: 37.
Kim JH, Yu CH, Yhee JY, Im KS, Sur JH (2010) Lymphocyte infiltration, expression of interleukin (IL)-1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. J Comp Pathol 142: 177-186.
Kuan EL, Ziegler SF (2018) A tumor-myeloid cell axis, mediated via the cytokines IL-1α and TSLP, promotes the progression of breast can-cer. Nat Immunol 19: 366-374.
Kumar S, Kishimoto H, Chua HL, Badve S, Miller KD, Bigsby RM, Nakshatri H (2003) Interleukin-1α promotes tumour growth and ca-chexia in MCF-7 xenograft model of breast cancer. Am J Pathol 163: 2531-2541.
Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK (2005) Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8: 63-71.
Li L, Chen L, Zhang W, Liao Y, Chen J, Shi Y, Luo S (2017) Serum cytokine profile in patients with breast cancer. Cytokine 89: 173-178.
Lyon DE, McCain NL, Walter J, Schubert C (2008) Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res 57: 51-58.
Machado VS, Crivellenti LZ, Bottari NB, Tonin AA, Pelinson LP, Borin-Crivellenti S, Santana AE, Torbitz VD, Moresco RN, Duarte T, Duarte MM, Schetinger MR, Morsch VM, Jaques JA, Tinucci-Costa M, Da Silva AS (2015) Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma. Pathol Res Pract 211: 677-681.
Malik A, Kanneganti TD (2018) Function and regulation of IL-1α in inflammatory diseases and cancer. Immunol Rev 281: 124-137.
Maund SL, Barclay WW, Hover LD, Axanova LS, Sui G, Hipp JD, Fleet JC, Thorburn A, Cramer SD (2011) Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells. Cancer Res 71: 5276-5286.
Maund SL, Shi L, Cramer SD (2013) A role for interleukin-1 alpha in the 1,25 dihydroxyvitamin D3 response in mammary epithelial cells. PLoS One 8: e81367.
Mohamed MM (2012) Monocytes conditioned media stimulate fibronectin expression and spreading of inflammatory breast cancer cells in three-dimensional culture: A mechanism mediated by IL-8 signaling pathway. Cell Commun Signal 10: 3.
Monkong N, Thitiyanaporn C, Niyatiwatchanchai N, Jaroensong T (2020) Investigation of serum interleukin-8 level and clinicopathological parameters in canine mammary gland tumors. Vet Integr Sci 18: 173-182.
Pena L, De Andres PJ, Clemente M, Cuesta P, Perez-Alenza MD (2013) Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. Vet Pathol 50: 94-105.
Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256: 137-165.
Salas Y, Marquez A, Diaz D, Romero L (2015) Epidemiolo gical study of mammary tumors in female dogs diagnosed during the period 2002-2012. A growing animal health problem. PLoS One 10: e0127381.
Salvatore V, Teti G, Focaroli S, Mazzotti MC, Mazzotti A, Falconi M (2017) The tumor microenvironment promotes cancer progression and cell migration. Oncotarget 8: 9608-9616.
Salven P, Hattori K, Heissig B, Rafii S (2002) Interleukin-1 alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflam-matory cell VEGF synthesis and secretion. FASEB J 16: 1471-1473.
Simeone AM, Nieves-Alicea R, McMurtry VC, Colella S, Krahe R, Tari AM (2007) Cyclooxygenase-2 uses the protein kinase C/interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells. Int J Oncol 30: 785-792.
Singer CF, Hudelist G, Gschwantler-Kaulich D, Fink -Retter A, Mueller R, Walter I, Czerwenka K, Kubista E (2006) Interleukin-1 alpha protein secretion in breast cancer is associated with poor differentiation and estrogen receptor alpha negativity. Int J Gynecol Cancer 16 (Suppl 2): 556-559.
Sleeckx N, de Rooster H, Veldhuis Kroeze EJ, Van Ginneken C, Van Brantegem L (2011) Canine mammary tumours, an overview. Reprod Domest Anim 46: 1112-1131.
Tjomsland V, Spangeus A, Vӓlilӓ J, Sandstrӧm P, Borch K, Druid H, Falkmer S, Falkmer U, Messmer D, Larsson M (2011) Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts. Neo-plasia 13: 664-675.
Todorović-Raković N, Milovanović J (2013) Interleukin-8 in breast cancer progression. J Interferon Cytokine Res 33: 563-570.
Yokoe T, Iino Y, Takei H, Horiguchi J, Koibuchi Y, Maemura M, Ohwada S, Morishita Y (1997) Changes of cytokines and thyroid function in patients with recurrent breast cancer. Anticancer Res 17: 695-699.
Yuan A, Chen JJ, Yao PL, Yang PC (2005) The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci 10: 853-865.